Connection

Evangelos Terpos to Prognosis

Back to Details
This is a "connection" page, showing publications Evangelos Terpos has written about Prognosis.
Evangelos Terpos
Connection Strength
0.216
Prognosis
  1. Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival. Ann Hematol. 2018 Sep; 97(9):1671-1682.
    View in: PubMed
    Score: 0.034
  2. Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2018 06; 18(6):431-437.
    View in: PubMed
    Score: 0.034
  3. Increased expression of platelet derived growth factor receptor ß on trephine biopsies correlates with advanced myeloma. J BUON. 2017 Jul-Aug; 22(4):1032-1037.
    View in: PubMed
    Score: 0.032
  4. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016. Am Soc Clin Oncol Educ Book. 2016; 35:e407-17.
    View in: PubMed
    Score: 0.029
  5. High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents. Leuk Res. 2010 Mar; 34(3):399-402.
    View in: PubMed
    Score: 0.019
  6. Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood. 2003 Aug 01; 102(3):1064-9.
    View in: PubMed
    Score: 0.012
  7. A revised international prognostic score system for Waldenström's macroglobulinemia. Leukemia. 2019 11; 33(11):2654-2661.
    View in: PubMed
    Score: 0.009
  8. Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome. Ann Hematol. 2019 Jun; 98(6):1427-1434.
    View in: PubMed
    Score: 0.009
  9. Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis. Amyloid. 2018 Dec; 25(4):234-241.
    View in: PubMed
    Score: 0.009
  10. Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients. Leuk Lymphoma. 2019 03; 60(3):619-628.
    View in: PubMed
    Score: 0.009
  11. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies. Eur J Haematol. 2017 Nov; 99(5):409-414.
    View in: PubMed
    Score: 0.008
  12. Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy. Am J Hematol. 2017 Jul; 92(7):632-639.
    View in: PubMed
    Score: 0.008
  13. Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis. Leuk Lymphoma. 2006 Aug; 47(8):1553-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.